|
Volumn 114, Issue 13, 2009, Pages 2849-2850
|
The role of CBFβ in AML1-ETO's activity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AML1 ETO PROTEIN;
CBF BETA PROTEIN;
CHIMERIC PROTEIN;
PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;
PROTEIN;
PROTEIN INHIBITOR;
TRANSCRIPTION FACTOR ETV6;
TRANSCRIPTION FACTOR RUNX1;
UNCLASSIFIED DRUG;
AML1 ETO FUSION PROTEIN, HUMAN;
AML1-ETO FUSION PROTEIN, HUMAN;
CBFB PROTEIN, HUMAN;
CORE BINDING FACTOR BETA;
ONCOPROTEIN;
RUNX1T1 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
AMINO ACID SUBSTITUTION;
BINDING AFFINITY;
BONE MARROW CELL;
CALORIMETRY;
GENE MUTATION;
HUMAN;
HYDROPHOBICITY;
LETTER;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DOMAIN;
PROTEIN INTERACTION;
PROTEIN PURIFICATION;
PROTEIN STRUCTURE;
CHEMICAL STRUCTURE;
CHEMISTRY;
GENETICS;
METABOLISM;
MISSENSE MUTATION;
NOTE;
PHYSIOLOGY;
PROTEIN TERTIARY STRUCTURE;
CORE BINDING FACTOR ALPHA 2 SUBUNIT;
CORE BINDING FACTOR BETA SUBUNIT;
HUMANS;
MODELS, MOLECULAR;
MUTATION, MISSENSE;
ONCOGENE PROTEINS, FUSION;
PROTEIN BINDING;
PROTEIN STRUCTURE, TERTIARY;
PROTO-ONCOGENE PROTEINS;
TRANSCRIPTION FACTORS;
|
EID: 70350515487
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2009-07-231233 Document Type: Letter |
Times cited : (16)
|
References (6)
|